Cargando…
One Step Into the Future: New iPSC Tools to Advance Research in Parkinson’s Disease and Neurological Disorders
Studying Parkinson’s disease (PD) in the laboratory presents many challenges, the main one being the limited availability of human cells and tissue from affected individuals. As PD is characterized by a loss of dopaminergic (DA) neurons in the brain, it is nearly impossible for researchers to access...
Autores principales: | Mohamed, Nguyen-Vi, Larroquette, Frédérique, Beitel, Lenore K., Fon, Edward A., Durcan, Thomas M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6597965/ https://www.ncbi.nlm.nih.gov/pubmed/30741685 http://dx.doi.org/10.3233/JPD-181515 |
Ejemplares similares
-
A Multistep Workflow to Evaluate Newly Generated iPSCs and Their Ability to Generate Different Cell Types
por: Chen, Carol X.-Q., et al.
Publicado: (2021) -
iPSC-Based Cell Therapy: An Important Step Forward
por: Rao, Mahendra
Publicado: (2013) -
The Possible Future Roles for iPSC-Derived Therapy for Autoimmune Diseases
por: Hew, Meilyn, et al.
Publicado: (2015) -
Advancing Drug Discovery for Neurological Disorders Using iPSC-Derived Neural Organoids
por: Costamagna, Gianluca, et al.
Publicado: (2021) -
Leveraging iPSC technology to assess neuro-immune interactions in neurological and psychiatric disorders
por: Michalski, Christina, et al.
Publicado: (2023)